Tuberculosis and Respiratory Diseases

  • 제62권3호
  • /
  • Pages.184-191
  • /
  • 2007
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지

흉막 결핵의 진단에 있어서 흉수 검체양에 따른 중합효소연쇄반응 검사의 민감도

Sensitivity of Polymerase Chain Reaction for Pleural Tuberculosis according to the Amount of Pleural Effusion Specimens

  • 문진욱 (이화여자대학교 의과대학 내과학교실)
  • Moon, Jin Wook (Department of Internal Medicine, Ewha Womans University College of Medicine)
  • 투고 : 2007.02.08
  • 심사 : 2007.02.28
  • 발행 : 2007.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

연구 배경: 결핵성 흉막염의 진단에 있어서 흉수에 대한 중합효소연쇄반응 검사는 매우 낮은 민감도를 보였으며, 이는 흉수 내의 결핵균의 수가 적은 데에 기인하는 것으로 추정된다. 이번 연구에서는 흉수의 검체양을 증가시켰을 때 결핵성 흉수에 대한 중합효소연쇄반응 검사의 민감도가 향상되는지를 알아보고자 하였다. 방 법: 결핵성 흉막염에 대한 감별 진단이 필요하였던 53명의 환자에 대하여 전향적인 연구를 시행하였다. 각각의 환자로부터 얻은 흉수를 10 ml, 25 ml, 50 ml로 양을 달리 하여 결핵균에 대한 중합효소연쇄반응 검사를 시행하였으며, Cobas Amplicor MTB (Roche Diagnostic Systems)를 이용하였다. 결핵성 흉막염은 흉수에서 결핵균이 배양된 경우, 흉막 생검에서 결핵이 진단된 경우, 가래에서 결핵균이 배양된 경우 및 기타 원인이 배제된 상태에서 임상적으로 결핵성 흉수가 의심되며 항결핵제 투약으로 흉수가 호전된 경우를 포함하였다. 결 과: 53명의 환자 중 26명이 결핵성 흉막염으로 진단되었다. 흉수에 대한 항산균 바름질, 결핵균 배양, 아데노신 디아미나아제 측정 및 흉막 생검의 민감도는 각각 3.8%, 15.4%, 88.5%, 84.6%이었다. 10 ml, 25 ml, 50 ml의 흉수를 이용한 결핵균 중합효소연쇄반응 검사는 각각 3명(11.5%), 4명(15.4%), 3명(11.5%)에서 양성이었으며, 통계적으로 유의한 차이를 보이지 않았다(p>0.05, symmetry exact 검사). 결 론: 결핵균의 수가 극히 적을 것으로 예상되는 흉수 등의 검사물에 대해서는 결핵균 중합효소연쇄반응 검사의 임상적 유용성이 극히 제한적이며, 검사물의 양을 증가시키더라도 민감도는 향상되지 않는다.

Background: For the diagnosis of pleural tuberculosis, polymerase chain reaction (PCR) of pleural effusion specimens has shown very low sensitivity, which might be due to the small number of bacilli in the samples. The purpose of this investigation is to determine whether the sensitivity of PCR testing can be improved when increasing the amount of pleural effusion specimens. Methods: We prospectively analyzed pleural effusion specimens obtained from 53 patients for whom the exclusion of the possibility of tuberculous pleural effusion was necessary. We performed Mycobacterium tuberculosis PCR testing using the Cobas Amplicor MTB test (Roche Diagnostic Systems) with three different amounts (10ml, 25ml, and 50ml) of pleural effusion specimen in each patient. Pleural tuberculosis was defined as having one of the following: culture-positive pleural fluid sample, histopathologic finding consistent with tuberculosis on pleural biopsy, culture-positive sputum specimen, and/or positive response to anti-tuberculous medication without other possible causes of pleural effusion. Results: Of the 53 patients, 26 received the diagnosis of pleural tuberculosis. The sensitivities of AFB smearing, Mycobacterium tuberculosis culture of pleural effusion specimen, pleural biopsy, and measurement of ADA were 3.8%, 15.4%, 84.6%, and 88.5%, respectively. The results of PCR testing were positive for 3 (11.5%), 4 (15.4%), and 3 (11.5%) of the 26 patients when using 10ml, 25ml, and 50ml of pleural effusion specimens, respectively. These results did not show a statistically significant difference in the sensitivity of PCR testing when increasing the amount of pleural effusion samples (p>0.05, symmetry exact test). Conclusion: For specimens such as pleural effusion, in which the bacillary load is very low, the clinical utility of PCR testing seems highly limited with the kits designed for the diagnosis of pulmonary tuberculosis. An increased amount of pleural effusion sample does not improve the sensitivity of PCR testing.

키워드

참고문헌

  1. Menzies D. Issues in the management of contacts of patients with active pulmonary tuberculosis. Can J Public Health 1997;88:197-201
  2. Behr MA, Warren SA, Salamon H, Hopewell PC, Ponce de Leon A, Daley CL, et al. Transmission of Mycobacterium tuberculosis from patients smearnegative for acid-fast bacilli. Lancet 1999;353:444-9 https://doi.org/10.1016/S0140-6736(98)03406-0
  3. Toman K. Tuberculosis case-finding and chemotherapy: questions and answers. Geneva, Switzerland: World health organization; 1979
  4. Al Zahrani K, Al Jahdali H, Poirier L, Rene P, Gennaro ML, Menzies D. Accuracy and utility of commercially available amplification and serologic tests for the diagnosis of minimal pulmonary tuberculosis. Am J Respir Crit Care Med 2000; 162:1323-9 https://doi.org/10.1164/ajrccm.162.4.9912115
  5. Ogawa K, Koga H, Hirakata Y, Tomono K, Tashiro T, Kohno S. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion. Tuber Lung Dis 1997;78:29-34 https://doi.org/10.1016/S0962-8479(97)90013-7
  6. Iseman MD. A clinician's guide to tuberculosis. Philadelphia, PA: Lippincott Williams & Wilkins; 2000
  7. American thoracic society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000;161:1376-95 https://doi.org/10.1164/ajrccm.161.4.16141
  8. Kolk AH, Schuitema AR, Kuijper S, van Leeuwen J, Hermans PW, van Embden JD, et al. Detection of Mycobacterium tuberculosis in clinical samples by using polymerase chain reaction and a nonradioactive detection system. J Clin Microbiol 1992;30:2567-75
  9. de Wit D, Maartens G, Steyn L. A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion. Tuber Lung Dis 1992;73:262-7 https://doi.org/10.1016/0962-8479(92)90130-C
  10. de Lassence A, Lecossier D, Pierre C, Cadranel J, Stern M, Hance AJ. Detection of mycobacterial DNA in pleural fluid from patients with tuberculous pleurisy by means of the polymerase chain reaction: comparison of two protocols. Thorax 1992;47:265-9 https://doi.org/10.1136/thx.47.4.265
  11. Querol JM, Minguez J, Garcia-Sanchez E, Farga MA, Gimeno C, Garcia-de-Lomas J. Rapid diagnosis of pleural tuberculosis by polymerase chain reaction. Am J Respir Crit Care Med 1995;152:1977-81 https://doi.org/10.1164/ajrccm.152.6.8520765
  12. Villegas MV, Labrada LA, Saravia NG. Evaluation of polymerase chain reaction, adenosine deaminase, and interferon-gamma in pleural fluid for the differential diagnosis of pleural tuberculosis. Chest 2000;118: 1355-64 https://doi.org/10.1378/chest.118.5.1355
  13. Nagesh BS, Sehgal S, Jindal SK, Arora SK. Evaluation of polymerase chain reaction for detection of Mycobacterium tuberculosis in pleural fluid. Chest 2001;119:1737-41 https://doi.org/10.1378/chest.119.6.1737
  14. Moon JW, Chang YS, Kim SK, Kim YS, Lee HM, Kim SK, et al. The clinical utility of polymerase chain reaction for the diagnosis of pleural tuberculosis. Clin Infect Dis 2005;41:660-6 https://doi.org/10.1086/432474
  15. World Health Organization. Laboratory Services in Tuberculosis Control. Part III: Culture WHO/TB/ 98.258. Geneva, Switzerland: World Health Organization; 1998
  16. Giusti G, Galanti B. Methods of enzyme analysis. New York, NY: Academic Press; 1983
  17. Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973;63:88-92 https://doi.org/10.1378/chest.63.1.88
  18. Ellner JJ. Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med 1978;89:932-3
  19. Stead WW, Eichenholz A, Stauss HK. Operative and pathologic findings in twenty-four patients with syndrome of idiopathic pleurisy with effusion, presumably tuberculous. Am Rev Tuberc 1955;71: 473-502
  20. Light RW. Pleural diseases. Philadelphia, PA: Lea & Febiger; 1983
  21. Nightingale SL. From the Food and Drug Administration. JAMA 1996;275:585 https://doi.org/10.1001/jama.275.8.585
  22. Centers for Disease Control and Prevention. From the Centers for Disease Control and Prevention. Update: Nucleic acid amplification tests for tuberculosis. JAMA 2000;284:826 https://doi.org/10.1001/jama.284.7.826
  23. Shamputa IC, Rigouts And L, Portaels F. Molecular genetic methods for diagnosis and antibiotic resistance detection of mycobacteria from clinical specimens. APMIS 2004;112:728-52 https://doi.org/10.1111/j.1600-0463.2004.apm11211-1203.x
  24. Ehlers S, Ignatius R, Regnath T, Hahn H. Diagnosis of extrapulmonary tuberculosis by Gen-Probe amplified Mycobacterium tuberculosis direct test. J Clin Microbiol 1996;34:2275-9
  25. Pfyffer GE, Kissling P, Jahn EM, Welscher HM, Salfinger M, Weber R. Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol 1996;34:834-41
  26. Vlaspolder F, Singer P, Roggeveen C. Diagnostic value of an amplification method (Gen-Probe) compared with that of culture for diagnosis of tuberculosis. J Clin Microbiol 1995;33:2699-703
  27. Carpentier E, Drouillard B, Dailloux M. Diagnosis of tuberculosis by Amplicor Mycobacterium tuberculosis test: a multicenter study. J Clin Microbiol 1995; 33:3106-10
  28. Shah S, Miller A, Mastellone A. Rapid diagnosis of tuberculosis in various biopsy and body fluid specimens by the AMPLICOR Mycobacterium tuberculosis polymerase chain reaction test. Chest 1998;113:1190-4 https://doi.org/10.1378/chest.113.5.1190
  29. Levidiotou S, Vrioni G, Galanakis E, Gesouli E, Pappa C, Stefanou D. Four-year experience of use of the Cobas Amplicor system for rapid detection of Mycobacterium tuberculosis complex in respiratory and nonrespiratory specimens in Greece. Eur J Clin Microbiol Infect Dis 2003;22:349-56 https://doi.org/10.1007/s10096-003-0931-5
  30. Reischl U, Lehn N, Wolf H, Naumann L. Clinical evaluation of the automated COBAS AMPLICOR MTB assay for testing respiratory and nonrespiratory specimens. J Clin Microbiol 1998;36:2853-60
  31. Ruiz-Manzano J, Manterola JM, Gamboa F. Detection of Mycobacterium tuberculosis in paraffin-embedded pleural biopsy specimens by commercial ribosomal RNA and DNA amplification kits. Chest 2000;118: 648-55 https://doi.org/10.1378/chest.118.3.648